Open AccessTreatment outcome of docetaxel plus prednisolone for metastatic castration-resistant prostate cancer in Korea
Author(s) -
In-Chang Cho,
Jae Young Joung,
Ho Kyung Seo,
Jinsoo Chung,
Weon Seo Park,
Kang Hyun Lee
Publication year - 2014
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.136546
Subject(s) - docetaxel , medicine , prostate cancer , hazard ratio , prednisolone , chemotherapy , regimen , oncology , prostate specific antigen , cancer , chemotherapy regimen , surgery , confidence interval
We retrospectively reviewed the treatment outcomes of docetaxel plus prednisolone chemotherapy in Korean men with metastatic castration-resistant prostate cancer (mCRPC).